Jharkhand Drug Price Board Hits 97% Target in Monitoring Efforts

The Jharkhand Drug Price Monitoring Board announced that it has achieved 97% of its drug‑price monitoring targets for the year, marking a notable improvement in the state’s pharmaceutical oversight. The board’s mandate includes reviewing the prices of essential medicines and ensuring they remain within the prescribed limits. By meeting the majority of its objectives, the board aims to curb excessive pricing and protect patients from inflated costs. The success is expected to strengthen public confidence in the state’s healthcare regulation and could serve as a model for other states seeking to tighten drug price controls.